Masataka Kuroda

发表

Discovery of evocalcet, a next-generation calcium-sensing receptor agonist for the treatment of hyperparathyroidism.

T. Sakairi, Y. Moritani, H. Fukuda, 2018, Bioorganic & medicinal chemistry letters.

Utilizing public and private sector data to build better machine learning models for the prediction of pharmacokinetic parameters.

K. Mizuguchi, Tsuyoshi Esaki, T. Honma, 2022, Drug discovery today.

Structure-Activity Relationships of Anti-microRNA Oligonucleotides Containing Cationic Guanidine-Modified Nucleic Acids.

S. Obika, Masataka Kuroda, K. Yasukawa, 2022, Journal of medicinal chemistry.

A novel descriptor based on atom-pair properties

Masataka Kuroda, Masataka Kuroda, 2017, Journal of Cheminformatics.

Latent inter-organ mechanism of idiopathic pulmonary fibrosis unveiled by a generative computational approach

Thomas N. Sato, T. Niwa, T. Ogura, 2023, bioRxiv.

Structural dynamics of the N‐terminal SH2 domain of PI3K in its free and CD28‐bound states

K. Mizuguchi, M. Oda, T. Kawakami, 2022, The FEBS journal.

A public-private partnership to enrich the development of in silico predictive models for pharmacokinetic and cardiotoxic properties.

K. Mizuguchi, T. Honma, Tomohiro Sato, 2021, Drug discovery today.

The prediction of food effect on drug oral absorption by machine learning

Hitoshi Kawashima, Reiko Watanabe, Masataka Kuroda, 2020 .

Development of an In Silico Prediction Model for P-glycoprotein Efflux Potential in Brain Capillary Endothelial Cells toward the Prediction of Brain Penetration.

K. Mizuguchi, Tsuyoshi Esaki, Hitoshi Kawashima, 2021, Journal of medicinal chemistry.